The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2)
Clinical trial NCT05624827 · UNKNOWN
Trial details
- NCT number
- NCT05624827
- Sponsor
- University Medical Centre Maribor
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-01
- Primary completion
- 2023-09-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.